杭州市45~69岁人群非酒精性脂肪性肝病与2型糖尿病相关性研究

doi:10.19485/j.cnki.issn2096-5087.2020.08.012

Preventive Medicine

2020, Vol. 32

Issue (8): 809-812 DOI: 10.19485/j.cnki.issn2096-5087.2020.08.012

Current Issue | Archive | Adv Search

The relationship between non-alcoholic fatty liver disease and type 2 diabetes mellitus in people aged 45 to 69 years in Hangzhou

ZHOU Ruifen, DU Qiuyju, YAO Guoping, et al

Abstract
Figure/Table
References
Related Citation (1)

[1] 中华医学会肝病学分会脂肪肝,酒精性肝病学组中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018更新版)[J].中华肝脏病杂志,2018,26(3):195-203.
[2] RINELLA M E.Nonalcoholic fatty liver disease:a systematic review[J].JAMA,2015,313(22):2263-2273.
[3] YOUNOSIS Z M,KOENIG A B,ABDELATIF D,et al.Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J].Hepatology,2016,64(1):73-84.
[4] ZHU J Z,ZHOU Q Y,WANG Y M,et a1.Prevalence of fatty liver disease and the economy in China:a systematic review[J].World J Gastroenterol,2015,21(18):5695-5706.
[5] SHU L,SHEN X M,LI C,et al.Dietary patterns are associated with type 2 diabetes mellitus among middle-aged adults in Zhejiang Province,China[J].Nutr J,2017,16(1):81.
[6] CHEN G Y,CAO H X,LI F,et al.New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China:Shanghai Baosteel Cohort[J].J Diabetes Investig,2016,7(2):206-211.
[7] TILG H,MOSCHEN A R,RODEN M.NAFLD and diabetes mellitus[J].Nat Rev Gastroenterol Hepatol,2017,14(1):32-42.
[8] 蒋剑波,林玲萍,杜丽云,等.杭州市中年人群三种膳食模式与代谢综合征的关系研究[J].预防医学,2018,30(12):1222-1225,1230.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[10] 谭利明,陈露,龙鸣燕,等.中老年人群高血压患病的空间分布及影响因素分析[J].预防医学,2019,31(3):236-245.
[11] YU X L,SHU L,SHEN X M,et al.Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese:an observational study[J].Medicine(Baltimore),2017,96(39):e8164.
[12] 王卫光,章小艳,斯彩娟,等.碳水化合物计数法对糖尿病合并非酒精性脂肪肝患者的疗效观察[J].中华全科医学,2019,17(6):981-983,1017.
[13] PARK S K,SEO M H,SHIN H C,et al.Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men:5-year prospective cohort study[J].Hepatology,2013,57(4):1378-1383.
[14] DANFORD C J,LAI M.NAFLD:a multisystem disease that requires a multidisciplinary approach[J].Frontline Gastroenterol,2019,10(4):328-329.
[15] PERRY R J,SAMUEL V T,PETERSEN K F,et al.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes[J].Nature,2014,510(7503):84-91.
[16] PARRINELLO C M,LUTSEY P L,BALLANTYNE C M,et al.Six-year change in high-sensitivity C-reactive protein and risk of diabetes,cardiovascular disease,and mortality[J].Am Heart J,2015,170(2):380-389.
[17] SAMUEL V T,SHULMAN G I.Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases[J].Cell Metab,2018,27(1):22-41.
[18] SUNG K C,SEO D C,LEE S J,et al.Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese[J].Nutr Metab Cardiovasc Dis, 2019,29(5):489-495.
[19] 卞华, 高鑫.非酒精性脂肪性肝病与2型糖尿病[J].中华糖尿病杂志,2016,8(9):516.
[20] LI Q,WANG X,NI Y,et al.Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women[J].Lipids Health Dis,2019,18(1):155.